StockData
OS Therapies Inc logo

OS Therapies Inc (OSTX) income statement

OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.92+0.18 (+23.51%)

Close on Nov 18, 2026Market cap $42.43MP/E –Yield –

OS Therapies Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
614.3%

Financial strength

Current ratio
0.18
Debt to equity
–
Debt to assets
–
Cash to current liabilities
1.0%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?